OtherBASIC SCIENCE INVESTIGATIONS
Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET
Charles M. Laymon, N. Scott Mason, W. Gordon Frankle, Jonathan P. Carney, Brian J. Lopresti, Maralee Y. Litschge, Chester A. Mathis, James M. Mountz and Rajesh Narendran
Journal of Nuclear Medicine May 2009, 50 (5) 814-817; DOI: https://doi.org/10.2967/jnumed.108.058131
Charles M. Laymon
N. Scott Mason
W. Gordon Frankle
Jonathan P. Carney
Brian J. Lopresti
Maralee Y. Litschge
Chester A. Mathis
James M. Mountz
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET
Charles M. Laymon, N. Scott Mason, W. Gordon Frankle, Jonathan P. Carney, Brian J. Lopresti, Maralee Y. Litschge, Chester A. Mathis, James M. Mountz, Rajesh Narendran
Journal of Nuclear Medicine May 2009, 50 (5) 814-817; DOI: 10.2967/jnumed.108.058131
Human Biodistribution and Dosimetry of the D2/3 Agonist 11C-N-Propylnorapomorphine (11C-NPA) Determined from PET
Charles M. Laymon, N. Scott Mason, W. Gordon Frankle, Jonathan P. Carney, Brian J. Lopresti, Maralee Y. Litschge, Chester A. Mathis, James M. Mountz, Rajesh Narendran
Journal of Nuclear Medicine May 2009, 50 (5) 814-817; DOI: 10.2967/jnumed.108.058131